Thromb Haemost 1980; 43(01): 072
DOI: 10.1055/s-0038-1650020
Letter to the Editor
Schattauer GmbH Stuttgart

Antithrombin III: Substitutive Treatment of the Hereditary Deficiency

P Laharrague M. D.
Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France
Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France
,
R Biermé M. D.
Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France
Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France
,
A Cérène M. D.
Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France
Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France
,
A Boucays M. D.
Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France
Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France
,
P Massip M. D.
Laboratory of hematology and Cardiovascular department, CHU Toulouse Rangueil, 31054 Toulouse France
Department of infectious disease, CHU Toulouse Purpan, 31052 Toulouse France
› Author Affiliations
Further Information

Publication History

Received 04 December 1979

Accepted 07 January 1980

Publication Date:
13 July 2018 (online)

 
  • References

  • 1 Gruenberg J, Smallridge R, Rosenberg R. Inherited antithrombin III deficiency causing mesenteric venous infarction. A new clinical entity. Ann Surg 1975; 181: 791-794
  • 2 Thaler E, Niessner H, Kleinberger G, Gassner A. Antithrombin III replacement therapy in patients with congenital and acquired antithrombin III deficiency. Proc VIIth Int Congr Thrombos Haemostas London 1979
  • 3 Marciniak E, Farley C, De Simone P. Familial thrombosis due to antithrombin III deficiency. Blood 1974; 43: 219-231
  • 4 Tullis J, Watanabe K. Platelet antithrombin deficiency. A new clinical entity. Amer J Med 1978; 65: 472-478